South Africa's oncology clinical trials market is projected to grow from $82.2 Mn in 2022 to $138.5 Mn by 2030, registering a CAGR of 6.73% during the forecast period of 2022-30. The market will be driven by the country’s rising cancer burden and regulatory framework for clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Roche Holding AG & Aspen Pharmacare.
South Africa's oncology clinical trials market is projected to grow from $82.2 Mn in 2022 to $138.5 Mn by 2030, registering a CAGR of 6.73% during the forecast period of 2022-30. South Africa's economy is the third biggest in Africa and the most industrialized, technologically proficient, and diverse on the continent. South Africa is one of just eight African nations with an upper-middle-income economy. The South African Health Products Regulatory Authority (SAHPRA) is the regulatory body in charge of pharmaceuticals, clinical research, medical devices, and radiation safety in South Africa. SAHPRA is responsible for clinical trial monitoring, authorization, and examinations in South Africa. All cancers are becoming more common, with the overall number of cases more than doubling between 2019 and 2030, from roughly 62,000 to 1,21,000 incident cases. Breast, cervical, basal cell carcinoma, squamous cell carcinoma, and colorectal cancer are the most often diagnosed malignancies in South African women, whereas prostate, basal cell carcinoma, squamous cell carcinoma, and colorectal, and lung cancer are the most commonly diagnosed cancers in men.
The broad and diversified patient population is one of the primary benefits of conducting oncology clinical trials in South Africa. The nation has a high cancer burden, and the frequency of various forms of cancer varies by area, making it a suitable site for research requiring a broad patient group. The nation is home to numerous world-class cancer treatment and research facilities, including the Chris Hani Baragwanath Academic Hospital, the Charlotte Maxeke Johannesburg Academic Hospital, and the Groote Schuur Hospital in Cape Town. South Africa has achieved significant success in the development of its medical research infrastructure, and it is en route to becoming a key participant in oncology clinical trials. If the government continues to invest in medical research, the number of trials will undoubtedly expand, and South Africa will play an increasingly vital role in the worldwide fight against cancer.
Market Growth Drivers
The broad and diversified patient population is one of the primary benefits of conducting oncology clinical trials in South Africa. The nation has a high cancer burden, and the frequency of various forms of cancer varies by area, making it a suitable site for research requiring a broad patient group. The availability of competent medical facilities and well-trained medical staff is another benefit of conducting oncology clinical trials in South Africa. The nation is home to numerous world-class cancer treatment and research facilities, including the Chris Hani Baragwanath Academic Hospital, the Charlotte Maxeke Johannesburg Academic Hospital, and the Groote Schuur Hospital in Cape Town. The regulatory framework for clinical trials in South Africa is also appealing to researchers. The government has created clinical research legislation that complies with international norms, making it an appealing venue for foreign pharmaceutical firms wishing to perform clinical trials.
There are several challenges in conducting oncology clinical trials in South Africa. One of the most significant obstacles is a shortage of medical research funding, which might restrict the number of studies that can be undertaken. Also, there are some reservations regarding the possibility of ethical difficulties with informed consent, especially in rural communities where patients may not have access to the same degree of treatment or knowledge.
December 2022: The Cancer Moonshot in a factsheet released additional steps to lower Africa’s cancer burden as part of the US - Africa leaders conference according to which:
June 2022: Roche Pharma South Africa signed a Memorandum of Understanding (MOU) with Aspen, a worldwide speciality and branded multinational pharmaceutical firm.
February 2022: Debiopharm and Aspen partner to launch trelstar®, a prostate cancer drug, in South Africa
1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Clinical Trials Regulation in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
126.96.36.199 Product Applications and Services
188.8.131.52 Recent Developments
184.108.40.206 Partnerships Ecosystem
220.127.116.11 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
6. Methodology and Scope
By Phase (Revenue, USD Billion):
By Study Design Outlook (Revenue, USD Billion):
By Indication Outlook (Revenue, USD Billion):
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses